Literature DB >> 4115791

Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).

J M McKenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4115791     DOI： 10.1016/0026-0495(72)90012-1

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.

Authors:  D D Adams; T H Kennedy; R D Stewart
Journal:  Br Med J       Date:  1974-04-27

3.  Prolonged drug treatment of hyperthyroidism.

Authors:  B A Burrows; D W Slingerland
Journal:  Trans Am Clin Climatol Assoc       Date:  1977

4.  Does smoking increase relapse rates in Graves' disease?

Authors:  L E Kimball; E Kulinskaya; B Brown; C Johnston; N R Farid
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

5.  [The problems surrounding subtotal struma resection in hyperthyroidism with endocrinous Ophthalmopathy (author's transl)].

Authors:  J Schumann; V Grabs
Journal:  Langenbecks Arch Chir       Date:  1975-09-10

6.  Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.

Authors:  P Kendall-Taylor
Journal:  Br Med J       Date:  1973-07-14

7.  Neonatal hyperthyroidism and long-acting thyroid stimulator protector.

Authors:  J Nutt; F Clark; R G Welch; R Hall
Journal:  Br Med J       Date:  1974-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.